Advertisement
UK markets close in 7 hours 34 minutes

  • FTSE 100

    8,399.00
    -25.20 (-0.30%)
     

  • FTSE 250

    20,794.06
    -79.27 (-0.38%)
     

  • AIM

    807.20
    -2.74 (-0.34%)
     

  • GBP/EUR

    1.1699
    +0.0001 (+0.01%)
     

  • GBP/USD

    1.2717
    +0.0011 (+0.08%)
     

  • Bitcoin GBP

    55,795.61
    +3,228.33 (+6.14%)
     

  • CMC Crypto 200

    1,526.52
    +37.98 (+2.55%)
     

  • S&P 500

    5,308.13
    +4.86 (+0.09%)
     

  • DOW

    39,806.77
    -196.82 (-0.49%)
     

  • CRUDE OIL

    79.25
    -0.55 (-0.69%)
     

  • GOLD FUTURES

    2,424.40
    -14.10 (-0.58%)
     

  • NIKKEI 225

    38,946.93
    -122.75 (-0.31%)
     

  • HANG SENG

    19,250.67
    -385.55 (-1.96%)
     

  • DAX

    18,734.96
    -34.00 (-0.18%)
     

  • CAC 40

    8,153.62
    -42.34 (-0.52%)
     
Travel:

UK’s best city break revealed

This 'lively' and 'buzzing' city beat London and Cardiff in a new ranking

Merck fourth-quarter sales just miss Wall St. estimate

Reuters

(Reuters) - Merck & Co Inc reported lower sales, just below Wall Street estimates, hurt by competition from cheaper generic medicines. The second-biggest U.S. drugmaker said on Wednesday it earned $781 million (479 million pounds), or 26 cents per share, in the fourth quarter. That compared with $908 million, or 30 cents per share, in the year-earlier period. Company revenue fell 4 percent to $11.32 billion. Wall Street was expecting $11.36 billion, according to Thomson Reuters I/B/E/S. (Reporting by Ransdell Pierson; Editing by Jeffrey Benkoe)